Abstract
Uncertainty remains over optimal antithrombotic treatment of patients with atrial fibrillation presenting with myocardial infarction and/or undergoing percutaneous coronary intervention. We investigated the risk and time frame for bleeding following myocardial infarction/percutaneous coronary intervention in patients with atrial fibrillation according to antithrombotic treatment.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Circulation (Baltimore) |
| Vol/bind | 126 |
| Udgave nummer | 10 |
| Sider (fra-til) | 1185-93 |
| Antal sider | 9 |
| ISSN | 0009-7322 |
| DOI | |
| Status | Udgivet - 2012 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS